News
Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...
Moderna and Pfizer's shots were revised this year to target the KP.2 variant of SARS-CoV-2, the virus that causes COVID-19, as part of a now-annual process undertaken by the FDA and health ...
10d
MedPage Today on MSNOklahoma Applies for SNAP Waiver to Bar Payment for Sodas, Candy, Baked GoodsAlthough people should have the right to eat soda, candy, and other less nutritious foods, the federal government shouldn't ...
FDA Gives Full OK to Novavax COVID Shot for High-Risk Groups MONDAY, May 19, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 ...
Ritedose Pharmaceuticals has received the Food and Drug Administration’s approval for manufacturing and distributing generic albuterol sulfate inhalation solution, 0.5% (2.5 mg/0.5 ml).
Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer Treatment Provided by Dow Jones Jul 2, 2025, 3:39:00 PM. By Colin Kellaher .
Only adults 65+ or those with health risks ages 12–64 can get it The vaccine is the only protein-based COVID shot in the U.S. MONDAY, May 19, 2025 (HealthDay News) — The U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results